Global Biomedica s.r.o. is a Czech Republic-based startup specializing in the development and production of 3D-printed titanium spine fusion implants. Established in 2016, the company is positioned as a professional and innovative partner for 3D metal printing technology, particularly focused on low volume and niche products as well as series production. Their expertise spans across diverse industries including Health Care and Manufacturing, catering to sectors such as automotive, tooling, rapid prototyping, aerospace, industry, and medical devices. Global Biomedica boasts a comprehensive portfolio of sophisticated metals for direct metal laser sintering (DMLS), utilizing titanium, aluminum, maraging steel, stainless steel, etc. to meet the specified property profiles. Notably, the company has ventured into the production of orthopedic titanium implants, demonstrating prowess in the design, construction, and manufacturing of custom implants for traumatology, orthopedics, and cranial surgery, leveraging innovative and high-quality industrial 3D printing technologies. The startup adheres to ISO 13845 standards, underlining its commitment to quality and compliance within the medical devices space. With a focus on additive manufacturing, Global Biomedica leverages cutting-edge technology and manufacturing equipment, positioning itself as a global technology and quality leader in the field. While specific funding details are not available, the company's capabilities and market positioning make it an intriguing prospect for venture capital investors seeking opportunities within the health care and manufacturing sectors.
There is no investment information
No recent news or press coverage available for Global Biomedica s.r.o..